Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
609.00    -7.00 (-1.14%)
Bid:
609.00
Ask:
611.00
Spread: 2.00 (0.328%)
Market Cap: £530.59m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Management Change

27 Apr 2012 07:00

RNS Number : 1795C
Victrex PLC
27 April 2012
 



27 April 2012

 

Victrex plc

 

Management Change

 

Victrex plc ("the Company") today announces that Hichem M'Saad has been appointed as Managing Director of our Invibio® Biomaterial Solutions business unit ("Invibio"). Hichem will join the Company on 18 June 2012, succeeding Michael Callahan, who will remain on the Invibio board as leader of the spine business.

 

Prior to joining Invibio Hichem's career included 14 years at Applied Materials Inc, most recently as Corporate Vice President and General Manager of their Silicon Sector Group. Hichem holds a PhD in Materials Science and Engineering from the Massachusetts Institute of Technology and has extensive commercial and technical experience globally, in both start-up and mature businesses.

David Hummel, Chief Executive said:

 

"I am delighted that Hichem is joining Invibio. His wealth of general management and commercial experience in technology driven businesses will enable him to lead Invibio into a new phase of growth and realise opportunities in new and existing market areas. He will be a valuable asset to both Invibio and the wider Victrex Group.

 

I would like to thank Michael for his contribution to the Invibio business since its launch in 2001. Michael has supported us through a period of significant growth, development and investment, and will continue to deliver Invibio's strategy in the spine business going forward."

 

 

Enquiries

 

Victrex plc

01253 898067

David Hummel, Chief Executive

Steve Barrow, Finance Director

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne

0203 128 8100

 

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a provider of innovative, high performance thermoplastic polymers. We work with customers and end users globally to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business unit ('VPS') focuses on our transport, industrial and electronics markets and our Invibio® Biomaterial Solutions business unit ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUGPCUPPGAQ
Date   Source Headline
30th Nov 20189:39 amRNSTotal Voting Rights
28th Nov 20189:59 amRNSDirector Declaration
19th Nov 201812:14 pmRNSDirector/PDMR Shareholding
14th Nov 201810:01 amRNSDirector Declaration
31st Oct 201810:29 amRNSTotal Voting Rights
17th Oct 201811:23 amRNSDirector/PDMR Shareholding
28th Sep 20189:17 amRNSTotal Voting Rights
18th Sep 201812:06 pmRNSDirector/PDMR Shareholding
31st Aug 201810:52 amRNSTotal Voting Rights
22nd Aug 201812:46 pmRNSHolding(s) in Company
17th Aug 201811:31 amRNSDirector/PDMR Shareholding
31st Jul 201810:56 amRNSTotal Voting Rights
27th Jul 20184:01 pmRNSHolding(s) in Company
25th Jul 201811:16 amRNSDirector/PDMR Shareholding
25th Jul 20187:00 amRNSInterim Management Statement
17th Jul 201812:47 pmRNSDirector/PDMR Shareholding
29th Jun 20189:26 amRNSTotal Voting Rights
19th Jun 20183:25 pmRNSDirector/PDMR Shareholding
1st Jun 20189:04 amRNSBlock listing Interim Review
31st May 20181:29 pmRNSTotal Voting Rights
17th May 20182:37 pmRNSDirector/PDMR Shareholding
16th May 20183:47 pmRNSDirector/PDMR Shareholding
14th May 20187:01 amRNSDirectorate Change
14th May 20187:00 amRNSHalf-year Report
1st May 201811:42 amRNSTotal Voting Rights
30th Apr 201811:40 amRNSAdditional Listing
17th Apr 20184:28 pmRNSDirector/PDMR Shareholding
28th Mar 201810:00 amRNSGroup Financial Director Update
19th Mar 20183:13 pmRNSDirector/PDMR Shareholding
1st Mar 20182:22 pmRNSTotal Voting Rights
19th Feb 20184:30 pmRNSDirector/PDMR Shareholding
12th Feb 201810:32 amRNSDirectorate Change
12th Feb 201810:30 amRNSDirectorate Change
9th Feb 201811:50 amRNSResult of AGM
9th Feb 201811:24 amRNSDirector/PDMR Shareholding
9th Feb 20187:00 amRNSAGM & Q1 IMS
7th Feb 20184:16 pmRNSHolding(s) in Company
6th Feb 20181:44 pmRNSDirectorate Change
1st Feb 201812:13 pmRNSTotal Voting Rights
25th Jan 20189:49 amRNSHolding(s) in Company
17th Jan 20184:25 pmRNSDirector/PDMR Shareholding
4th Jan 201812:06 pmRNSNomination for election of Non-executive Directors
4th Jan 201812:00 pmRNSAnnual Financial Report
29th Dec 201710:00 amRNSTotal Voting Rights
19th Dec 20174:24 pmRNSDirector/PDMR Shareholding
18th Dec 201710:08 amRNSDirector/PDMR Shareholding
8th Dec 20171:19 pmRNSDirector/PDMR Shareholding
5th Dec 201711:39 amRNSDirector/PDMR Shareholding
5th Dec 20177:01 amRNSDirectorate Change
5th Dec 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.